| 排名 | 分析师 | 机构 | 行业 | 年度收益率 | 6个月收益率 | 3个月收益率 | 正收益比例 | 成分股数量 | 历史最大跌幅 | 更新日期 |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 华挺 | 财通证券 | 医药生物 | 27.47% | 29.11% | 5.28% | -6.67% | 4 | -50.33% | 2025-07-03 |
| 2 | 万鹏辉 | 国海证券 | 医药生物 | 27.44% | 12.07% | 18.66% | 50.00% | 5 | -3.00% | 2025-06-04 |
| 3 | 仰佳佳 | 申万宏源 | 医药生物 | 27.43% | 35.00% | 32.04% | 23.08% | 4 | -37.64% | 2025-04-17 |
| 4 | 仰佳佳 | 申万宏源 | 医药生物 | 27.42% | 26.36% | 18.60% | 23.08% | 1 | -37.64% | 2025-05-30 |
| 5 | 唐寅灏 | 中信证券 | 医药生物 | 27.40% | 22.06% | 30.27% | 85.71% | 6 | -8.47% | 2025-04-03 |
| 6 | 唐寅灏 | 中信证券 | 医药生物 | 27.38% | 21.80% | 31.07% | 85.71% | 9 | -8.47% | 2025-04-22 |
| 7 | 万鹏辉 | 国海证券 | 医药生物 | 27.35% | 12.19% | 21.10% | 50.00% | 5 | -3.00% | 2025-06-11 |
| 8 | 吴春红 | 江海证券 | 医药生物 | 27.33% | 29.28% | 7.83% | 27.27% | 6 | -25.67% | 2025-07-04 |
| 9 | 王班 | 民生证券 | 医药生物 | 27.29% | 30.67% | 23.27% | -21.43% | 15 | -61.25% | 2025-07-14 |
| 10 | 仰佳佳 | 申万宏源 | 医药生物 | 27.26% | 37.70% | 6.51% | 23.08% | 1 | -37.64% | 2025-07-11 |
| 11 | 周豫 | 太平洋 | 医药生物 | 27.25% | 33.83% | 27.11% | 21.21% | 23 | -55.62% | 2025-07-08 |
| 12 | 吴春红 | 江海证券 | 医药生物 | 27.25% | 22.14% | 10.58% | 27.27% | 5 | -25.67% | 2025-06-26 |
| 13 | 张林晚 | 上海证券 | 医药生物 | 27.25% | 21.80% | 20.61% | -100.00% | 1 | -18.93% | 2025-06-24 |
| 14 | 华挺 | 财通证券 | 医药生物 | 27.25% | 22.64% | 17.28% | -6.67% | 4 | -50.33% | 2025-06-04 |
| 15 | 袁聪敏 | 中信证券 | 医药生物 | 27.24% | 21.09% | 21.25% | 100.00% | 5 | 0.00% | 2025-04-18 |
| 16 | 阳景 | 浦银国际证券 | 医药生物 | 27.23% | 28.57% | 17.39% | 100.00% | 4 | 0.00% | 2025-05-06 |
| 17 | 杨松 | 天风证券 | 医药生物 | 27.21% | 19.39% | 21.91% | -40.89% | 24 | -72.65% | 2025-06-10 |
| 18 | 周豫 | 太平洋 | 医药生物 | 27.21% | 30.60% | 12.14% | 21.21% | 23 | -55.62% | 2025-07-04 |
| 19 | 王班 | 民生证券 | 医药生物 | 27.21% | 32.19% | 23.77% | -21.43% | 15 | -61.25% | 2025-07-15 |
| 20 | 华挺 | 财通证券 | 医药生物 | 27.21% | 27.21% | 4.50% | -6.67% | 4 | -50.33% | 2025-07-01 |